BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Abraham A, Krasnodembskaya A. Mesenchymal stem cell-derived extracellular vesicles for the treatment of acute respiratory distress syndrome. Stem Cells Transl Med. 2020;9:28-38. [PMID: 31647191 DOI: 10.1002/sctm.19-0205] [Cited by in Crossref: 54] [Cited by in F6Publishing: 56] [Article Influence: 18.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhao Y, Yan Z, Liu Y, Zhang Y, Shi J, Li J, Ji F. Effectivity of mesenchymal stem cells for bleomycin-induced pulmonary fibrosis: a systematic review and implication for clinical application. Stem Cell Res Ther 2021;12:470. [PMID: 34420515 DOI: 10.1186/s13287-021-02551-y] [Reference Citation Analysis]
2 Askenase PW. COVID-19 therapy with mesenchymal stromal cells (MSC) and convalescent plasma must consider exosome involvement: Do the exosomes in convalescent plasma antagonize the weak immune antibodies? J Extracell Vesicles 2020;10:e12004. [PMID: 33304473 DOI: 10.1002/jev2.12004] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 7.0] [Reference Citation Analysis]
3 Mansourabadi AH, Sadeghalvad M, Mohammadi-Motlagh HR, Rezaei N. The immune system as a target for therapy of SARS-CoV-2: A systematic review of the current immunotherapies for COVID-19. Life Sci 2020;258:118185. [PMID: 32750438 DOI: 10.1016/j.lfs.2020.118185] [Cited by in Crossref: 47] [Cited by in F6Publishing: 45] [Article Influence: 23.5] [Reference Citation Analysis]
4 Cao C, Zhang L, Shen J. Phosgene-Induced acute lung injury: Approaches for mechanism-based treatment strategies. Front Immunol 2022;13:917395. [DOI: 10.3389/fimmu.2022.917395] [Reference Citation Analysis]
5 Guo H, Su Y, Deng F. Effects of Mesenchymal Stromal Cell-Derived Extracellular Vesicles in Lung Diseases: Current Status and Future Perspectives. Stem Cell Rev Rep 2021;17:440-58. [PMID: 33211245 DOI: 10.1007/s12015-020-10085-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
6 Millar JE, Suen JY, McAuley DF, Fraser JF. Reply to Zhang and Hei: Mesenchymal Stem Cell-derived Exosomes: Are They Another Therapeutic Method for Extracorporeal Membrane Oxygenation-supported Acute Respiratory Distress Syndrome? Am J Respir Crit Care Med 2020;202:1603-4. [PMID: 32903045 DOI: 10.1164/rccm.202007-2995LE] [Reference Citation Analysis]
7 Lian J, Lin J, Zakaria N, Yahaya BH. Acute Lung Injury: Disease Modelling and the Therapeutic Potential of Stem Cells. Adv Exp Med Biol 2020;1298:149-66. [PMID: 32424492 DOI: 10.1007/5584_2020_538] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
8 Heng W, Bhavsar M, Han Z, Barker JH. Effects of Electrical Stimulation on Stem Cells. Curr Stem Cell Res Ther 2020;15:441-8. [PMID: 31995020 DOI: 10.2174/1574888X15666200129154747] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 C. Rodriguez H, Gupta M, Cavazos-escobar E, Montalvo E, F. El-amin S, Gupta A. Mesenchymal Stem Cells and Extracellular Vesicles: An Emerging Alternative to Combat COVID-19. Biotechnology to Combat COVID-19 [Working Title]. IntechOpen; 2021. [DOI: 10.5772/intechopen.97212] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Sang L, Guo X, Shi J, Hou S, Fan H, Lv Q. Characteristics and Developments in Mesenchymal Stem Cell Therapy for COVID-19: An Update. Stem Cells Int 2021;2021:5593584. [PMID: 34211556 DOI: 10.1155/2021/5593584] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Demir S, Erturk A, Gunal YD, Ozmen I, Zengin M, Yildiz D, Karaoz E, Karahan S, Senel E. Contribution of Bone Marrow-Derived Mesenchymal Stem Cells to Healing of Pulmonary Contusion-Created Rats. J Surg Res 2021;261:205-14. [PMID: 33450629 DOI: 10.1016/j.jss.2020.12.006] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Li C. Strengthening regulations, recent advances and remaining barriers in stem cell clinical translation in China: 2015-2021 in review. Pharmacol Res 2022;182:106304. [PMID: 35710062 DOI: 10.1016/j.phrs.2022.106304] [Reference Citation Analysis]
13 Ma Z, Yang KY, Huang Y, Lui KO. Endothelial contribution to COVID-19: an update on mechanisms and therapeutic implications. J Mol Cell Cardiol 2021;164:69-82. [PMID: 34838588 DOI: 10.1016/j.yjmcc.2021.11.010] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 11.0] [Reference Citation Analysis]
14 Samara A, Herlenius E. Is There an Effect of Fetal Mesenchymal Stem Cells in the Mother-Fetus Dyad in COVID-19 Pregnancies and Vertical Transmission? Front Physiol 2020;11:624625. [PMID: 33679426 DOI: 10.3389/fphys.2020.624625] [Reference Citation Analysis]
15 Derakhshan MA, Amani A, Faridi-Majidi R. State-of-the-Art of Nanodiagnostics and Nanotherapeutics against SARS-CoV-2. ACS Appl Mater Interfaces 2021;13:14816-43. [PMID: 33779135 DOI: 10.1021/acsami.0c22381] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
16 Leclaire M, Gimzewski J, Sharma S. A review of the biomechanical properties of single extracellular vesicles. Nano Select 2021;2:1-15. [DOI: 10.1002/nano.202000129] [Cited by in Crossref: 13] [Cited by in F6Publishing: 3] [Article Influence: 6.5] [Reference Citation Analysis]
17 Sütlüoğlu H, Özdemir Ö. May mesenchymal stem cell transplantation be a solution for COVID-19 induced cytokine storm? World J Transplant 2021; 11(8): 344-355 [PMID: 34447671 DOI: 10.5500/wjt.v11.i8.344] [Reference Citation Analysis]
18 Shaw TD, Krasnodembskaya AD, Schroeder GN, Zumla A, Maeurer M, O'Kane CM. Mesenchymal Stromal Cells: an Antimicrobial and Host-Directed Therapy for Complex Infectious Diseases. Clin Microbiol Rev 2021;:e0006421. [PMID: 34612662 DOI: 10.1128/CMR.00064-21] [Reference Citation Analysis]
19 Çetin İ, Topçul M. Can mesenchymal stem cells be used to treat COVID-19-induced pneumonia? (Review). Biomed Rep 2020;13:62. [PMID: 33194191 DOI: 10.3892/br.2020.1369] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
20 Zhou Y, Yang Y, Liang T, Hu Y, Tang H, Song D, Fang H. The regulatory effect of microRNA-21a-3p on the promotion of telocyte angiogenesis mediated by PI3K (p110α)/AKT/mTOR in LPS induced mice ARDS. J Transl Med 2019;17:427. [PMID: 31878977 DOI: 10.1186/s12967-019-02168-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
21 Chinnici CM, Russelli G, Bulati M, Miceli V, Gallo A, Busà R, Tinnirello R, Conaldi PG, Iannolo G. Mesenchymal stromal cell secretome in liver failure: Perspectives on COVID-19 infection treatment. World J Gastroenterol 2021; 27(17): 1905-1919 [PMID: 34007129 DOI: 10.3748/wjg.v27.i17.1905] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
22 Zhang L, Liu Q, Hu H, Zhao L, Zhu K. Progress in mesenchymal stem cell mitochondria transfer for the repair of tissue injury and treatment of disease. Biomedicine & Pharmacotherapy 2022;153:113482. [DOI: 10.1016/j.biopha.2022.113482] [Reference Citation Analysis]
23 Krasnodembskaya A. In reply. Stem Cells Transl Med 2020;9:815-6. [PMID: 32320529 DOI: 10.1002/sctm.20-0112] [Reference Citation Analysis]
24 Shafiee A, Moradi L, Lim M, Brown J. Coronavirus disease 2019: A tissue engineering and regenerative medicine perspective. Stem Cells Transl Med. 2021;10:27-38. [PMID: 32820868 DOI: 10.1002/sctm.20-0197] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
25 Masterson C, Horie S, McCarthy SD, Gonzalez H, Byrnes D, Brady J, Fandiño J, Laffey JG, O'Toole D. Hypercapnia in the critically ill: insights from the bench to the bedside. Interface Focus 2021;11:20200032. [PMID: 33628425 DOI: 10.1098/rsfs.2020.0032] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
26 Yasamineh S, Kalajahi HG, Yasamineh P, Gholizadeh O, Youshanlouei HR, Matloub SK, Mozafari M, Jokar E, Yazdani Y, Dadashpour M. Spotlight on therapeutic efficiency of mesenchymal stem cells in viral infections with a focus on COVID-19. Stem Cell Res Ther 2022;13:257. [PMID: 35715852 DOI: 10.1186/s13287-022-02944-7] [Reference Citation Analysis]
27 Oh JY, Kim E, Yun YI, Lee RH. Mesenchymal stromal cells for corneal transplantation: Literature review and suggestions for successful clinical trials. Ocul Surf 2021;20:185-94. [PMID: 33607323 DOI: 10.1016/j.jtos.2021.02.002] [Reference Citation Analysis]
28 Yao D, Ye H, Huo Z, Wu L, Wei S. Mesenchymal stem cell research progress for the treatment of COVID-19. J Int Med Res. 2020;48:300060520955063. [PMID: 32972277 DOI: 10.1177/0300060520955063] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
29 Li J, Wang X, Li N, Jiang Y, Huang H, Wang T, Lin Z, Xiong N. Feasibility of Mesenchymal Stem Cell Therapy for COVID-19: A Mini Review. Curr Gene Ther. 2020;20:285-288. [PMID: 32867652 DOI: 10.2174/1566523220999200820172829] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
30 Robinson MJ, Krasnodembskaya AD. Therapeutic targeting of metabolic alterations in acute respiratory distress syndrome. Eur Respir Rev 2020;29:200114. [PMID: 32620587 DOI: 10.1183/16000617.0114-2020] [Reference Citation Analysis]
31 Xu G, Wan H, Yi L, Chen W, Luo Y, Huang Y, Liu X. Berberine administrated with different routes attenuates inhaled LPS-induced acute respiratory distress syndrome through TLR4/NF-κB and JAK2/STAT3 inhibition. Eur J Pharmacol 2021;908:174349. [PMID: 34284014 DOI: 10.1016/j.ejphar.2021.174349] [Reference Citation Analysis]
32 Li S, Zhu H, Zhao M, Liu W, Wang L, Zhu B, Xie W, Zhao C, Zhou Y, Ren C, Liu H, Jiang X. When stem cells meet COVID-19: recent advances, challenges and future perspectives. Stem Cell Res Ther 2022;13:9. [PMID: 35012650 DOI: 10.1186/s13287-021-02683-1] [Reference Citation Analysis]
33 Ji F, Li L, Li Z, Jin Y, Liu W. Mesenchymal stem cells as a potential treatment for critically ill patients with coronavirus disease 2019. Stem Cells Transl Med 2020;9:813-4. [PMID: 32320535 DOI: 10.1002/sctm.20-0083] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 9.5] [Reference Citation Analysis]
34 Rezakhani L, Kelishadrokhi AF, Soleimanizadeh A, Rahmati S. Mesenchymal stem cell (MSC)-derived exosomes as a cell-free therapy for patients Infected with COVID-19: Real opportunities and range of promises. Chem Phys Lipids 2021;234:105009. [PMID: 33189639 DOI: 10.1016/j.chemphyslip.2020.105009] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
35 Lenzini S, Debnath K, Joshi JC, Wong SW, Srivastava K, Geng X, Cho IS, Song A, Bargi R, Lee JC, Mo GCH, Mehta D, Shin JW. Cell-Matrix Interactions Regulate Functional Extracellular Vesicle Secretion from Mesenchymal Stromal Cells. ACS Nano 2021. [PMID: 34677951 DOI: 10.1021/acsnano.1c03231] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
36 Mokrá D. Acute lung injury - from pathophysiology to treatment. Physiol Res 2020;69:S353-66. [PMID: 33464919 DOI: 10.33549/physiolres.934602] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
37 Ngai HW, Kim DH, Hammad M, Gutova M, Aboody K, Cox CD. Stem Cell‐based therapies for COVID‐19‐related acute respiratory distress syndrome. J Cellular Molecular Medi. [DOI: 10.1111/jcmm.17265] [Reference Citation Analysis]
38 Peswani Sajnani SL, Zhang Y, Vllasaliu D. Exosome-based therapies for mucosal delivery. Int J Pharm 2021;608:121087. [PMID: 34530100 DOI: 10.1016/j.ijpharm.2021.121087] [Reference Citation Analysis]
39 Li YE, Ajoolabady A, Dhanasekaran M, Ren J. Tissue repair strategies: What we have learned from COVID-19 in the application of MSCs therapy. Pharmacol Res 2022;182:106334. [PMID: 35779816 DOI: 10.1016/j.phrs.2022.106334] [Reference Citation Analysis]
40 Tan MI, Alfarafisa NM, Septiani P, Barlian A, Firmansyah M, Faizal A, Melani L, Nugrahapraja H. Potential Cell-Based and Cell-Free Therapy for Patients with COVID-19. Cells 2022;11:2319. [DOI: 10.3390/cells11152319] [Reference Citation Analysis]
41 Adugna DG. Current Clinical Application of Mesenchymal Stem Cells in the Treatment of Severe COVID-19 Patients: Review. Stem Cells Cloning 2021;14:71-80. [PMID: 34785907 DOI: 10.2147/SCCAA.S333800] [Reference Citation Analysis]
42 Qin H, Zhao A. Mesenchymal stem cell therapy for acute respiratory distress syndrome: from basic to clinics. Protein Cell. 2020. [PMID: 32519302 DOI: 10.1007/s13238-020-00738-2] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 13.0] [Reference Citation Analysis]
43 Banimohamad-Shotorbani B, Farajpour H, Sefat F, Khosroshahi SA, Shafaei H, Heidari Keshel S. Efficacy of mesenchymal stromal cells and cellular products in improvement of symptoms for COVID-19 and similar lung diseases. Biotechnol Bioeng 2021;118:2168-83. [PMID: 33629351 DOI: 10.1002/bit.27729] [Reference Citation Analysis]
44 Gurunathan S, Kang MH, Kim JH. Diverse Effects of Exosomes on COVID-19: A Perspective of Progress From Transmission to Therapeutic Developments. Front Immunol 2021;12:716407. [PMID: 34394121 DOI: 10.3389/fimmu.2021.716407] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
45 Chu M, Wang H, Bian L, Huang J, Wu D, Zhang R, Fei F, Chen Y, Xia J. Nebulization Therapy with Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes for COVID-19 Pneumonia. Stem Cell Rev Rep 2022. [PMID: 35665467 DOI: 10.1007/s12015-022-10398-w] [Reference Citation Analysis]
46 Wang J, Ma Y, Long Y, Chen Y. Extracellular Vesicle Derived From Mesenchymal Stem Cells Have Bidirectional Effects on the Development of Lung Cancer. Front Oncol 2022;12:914832. [DOI: 10.3389/fonc.2022.914832] [Reference Citation Analysis]
47 Al-Khawaga S, Abdelalim EM. Potential application of mesenchymal stem cells and their exosomes in lung injury: an emerging therapeutic option for COVID-19 patients. Stem Cell Res Ther 2020;11:437. [PMID: 33059757 DOI: 10.1186/s13287-020-01963-6] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 10.0] [Reference Citation Analysis]
48 Khalaj K, Figueira RL, Antounians L, Lauriti G, Zani A. Systematic review of extracellular vesicle-based treatments for lung injury: are EVs a potential therapy for COVID-19? J Extracell Vesicles 2020;9:1795365. [PMID: 32944185 DOI: 10.1080/20013078.2020.1795365] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 8.0] [Reference Citation Analysis]
49 Chen L, Qu J, Kalyani FS, Zhang Q, Fan L, Fang Y, Li Y, Xiang C. Mesenchymal stem cell-based treatments for COVID-19: status and future perspectives for clinical applications. Cell Mol Life Sci 2022;79. [DOI: 10.1007/s00018-021-04096-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
50 Akbari A, Rezaie J. Potential therapeutic application of mesenchymal stem cell-derived exosomes in SARS-CoV-2 pneumonia. Stem Cell Res Ther 2020;11:356. [PMID: 32795359 DOI: 10.1186/s13287-020-01866-6] [Cited by in Crossref: 30] [Cited by in F6Publishing: 35] [Article Influence: 15.0] [Reference Citation Analysis]
51 Mahajan A, Bhattacharyya S. A brief review on potential application of mesenchymal stem cell and secretome in combating mortality and morbidity in COVID-19 patients. Biomed J 2021;44:63-73. [PMID: 33727050 DOI: 10.1016/j.bj.2020.09.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
52 Liu J, Luo W, Chen Q, Chen X, Zhou G, Sun H. Curcumin sensitizes response to cytarabine in acute myeloid leukemia by regulating intestinal microbiota. Cancer Chemother Pharmacol. [DOI: 10.1007/s00280-021-04385-0] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
53 Gao Y, Raj JU. Extracellular Vesicles as Unique Signaling Messengers: Role in Lung Diseases. Compr Physiol 2020;11:1351-69. [PMID: 33294981 DOI: 10.1002/cphy.c200006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
54 Bari E, Ferrarotti I, Saracino L, Perteghella S, Torre ML, Corsico AG. Mesenchymal Stromal Cell Secretome for Severe COVID-19 Infections: Premises for the Therapeutic Use. Cells. 2020;9. [PMID: 32283815 DOI: 10.3390/cells9040924] [Cited by in Crossref: 63] [Cited by in F6Publishing: 56] [Article Influence: 31.5] [Reference Citation Analysis]
55 Mao GC, Gong CC, Wang Z, Sun MX, Pei ZP, Meng WQ, Cen JF, He XW, Lu Y, Xu QQ, Xiao K. BMSC-derived exosomes ameliorate sulfur mustard-induced acute lung injury by regulating the GPRC5A-YAP axis. Acta Pharmacol Sin 2021;42:2082-93. [PMID: 33654219 DOI: 10.1038/s41401-021-00625-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
56 Paris GC, Azevedo AA, Ferreira AL, Azevedo YMA, Rainho MA, Oliveira GP, Silva KR, Cortez EAC, Stumbo AC, Carvalho SN, de Carvalho L, Thole AA. Therapeutic potential of mesenchymal stem cells in multiple organs affected by COVID-19. Life Sci 2021;278:119510. [PMID: 33865879 DOI: 10.1016/j.lfs.2021.119510] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
57 Canham MA, Campbell JDM, Mountford JC. The use of mesenchymal stromal cells in the treatment of coronavirus disease 2019. J Transl Med 2020;18:359. [PMID: 32958009 DOI: 10.1186/s12967-020-02532-4] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
58 Abraham A, Krasnodembskaya A. Mesenchymal stem cell-derived extracellular vesicles for the treatment of acute respiratory distress syndrome. Stem Cells Transl Med. 2020;9:28-38. [PMID: 31647191 DOI: 10.1002/sctm.19-0205] [Cited by in Crossref: 54] [Cited by in F6Publishing: 56] [Article Influence: 18.0] [Reference Citation Analysis]
59 Zhang L, Hei F. Mesenchymal Stem Cell-derived Exosomes: Are They Another Therapeutic Method for Extracorporeal Membrane Oxygenation-supported Acute Respiratory Distress Syndrome? Am J Respir Crit Care Med 2020;202:1602-3. [PMID: 32903027 DOI: 10.1164/rccm.202007-2895LE] [Reference Citation Analysis]
60 Raghav A, Khan ZA, Upadhayay VK, Tripathi P, Gautam KA, Mishra BK, Ahmad J, Jeong GB. Mesenchymal Stem Cell-Derived Exosomes Exhibit Promising Potential for Treating SARS-CoV-2-Infected Patients. Cells 2021;10:587. [PMID: 33799966 DOI: 10.3390/cells10030587] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
61 Wang M, Yu F, Li P, Wang K. Emerging Function and Clinical Significance of Exosomal circRNAs in Cancer. Mol Ther Nucleic Acids 2020;21:367-83. [PMID: 32650235 DOI: 10.1016/j.omtn.2020.06.008] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 10.5] [Reference Citation Analysis]
62 Krishnan A, Muthusamy S, Fernandez FB, Kasoju N. Mesenchymal Stem Cell-Derived Extracellular Vesicles in the Management of COVID19-Associated Lung Injury: A Review on Publications, Clinical Trials and Patent Landscape. Tissue Eng Regen Med 2022. [PMID: 35384633 DOI: 10.1007/s13770-022-00441-9] [Reference Citation Analysis]
63 Li C, Zhao H, Wang B. Challenges for Mesenchymal Stem Cell-Based Therapy for COVID-19. Drug Des Devel Ther 2020;14:3995-4001. [PMID: 33061304 DOI: 10.2147/DDDT.S269407] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
64 Pourgholaminejad A, Pahlavanneshan S, Basiri M. COVID-19 immunopathology with emphasis on Th17 response and cell-based immunomodulation therapy: Potential targets and challenges. Scand J Immunol 2021;:e13131. [PMID: 34936112 DOI: 10.1111/sji.13131] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
65 Najafi-Ghalehlou N, Roudkenar MH, Langerodi HZ, Roushandeh AM. Taming of Covid-19: potential and emerging application of mesenchymal stem cells. Cytotechnology 2021;:1-46. [PMID: 33776206 DOI: 10.1007/s10616-021-00461-8] [Reference Citation Analysis]
66 Li K, Huang Z, Tian S, Chen Y, Yuan Y, Yuan J, Zou X, Zhou F. MicroRNA-877-5p alleviates ARDS via enhancing PI3K/Akt path by targeting CDKN1B both in vivo and in vitro. Int Immunopharmacol 2021;95:107530. [PMID: 33735715 DOI: 10.1016/j.intimp.2021.107530] [Reference Citation Analysis]
67 Qiao Q, Liu X, Yang T, Cui K, Kong L, Yang C, Zhang Z. Nanomedicine for acute respiratory distress syndrome: The latest application, targeting strategy, and rational design. Acta Pharm Sin B 2021;11:3060-91. [PMID: 33977080 DOI: 10.1016/j.apsb.2021.04.023] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 15.0] [Reference Citation Analysis]
68 Shi Q, Sun B, Wang D, Zhu Y, Zhao X, Yang X, Zhang Y. Circ6401, a novel circular RNA, is implicated in repair of the damaged endometrium by Wharton's jelly-derived mesenchymal stem cells through regulation of the miR-29b-1-5p/RAP1B axis. Stem Cell Res Ther 2020;11:520. [PMID: 33261656 DOI: 10.1186/s13287-020-02027-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
69 Li C, Wang B. Mesenchymal Stem/Stromal Cells in Progressive Fibrogenic Involvement and Anti-Fibrosis Therapeutic Properties. Front Cell Dev Biol 2022;10:902677. [DOI: 10.3389/fcell.2022.902677] [Reference Citation Analysis]
70 Yang J, Hu H, Zhang S, Jiang L, Cheng Y, Xie H, Wang X, Jiang J, Wang H, Zhang Q. [Human umbilical cord mesenchymal stem cell-derived exosomes alleviate pulmonary fibrosis in mice by inhibiting epithelial-mesenchymal transition]. Nan Fang Yi Ke Da Xue Xue Bao 2020;40:988-94. [PMID: 32895166 DOI: 10.12122/j.issn.1673-4254.2020.07.11] [Reference Citation Analysis]
71 Riazanski V, Mauleon G, Lucas K, Walker S, Zimnicka AM, McGrath JL, Nelson DJ. Real time imaging of single extracellular vesicle pH regulation in a microfluidic cross-flow filtration platform. Commun Biol 2022;5:13. [PMID: 35013561 DOI: 10.1038/s42003-021-02965-7] [Reference Citation Analysis]
72 Gupta A, Shivaji K, Kadam S, Gupta M, Rodriguez HC, Potty AG, El-Amin SF 3rd, Maffulli N. Immunomodulatory extracellular vesicles: an alternative to cell therapy for COVID-19. Expert Opin Biol Ther 2021;:1-10. [PMID: 33886388 DOI: 10.1080/14712598.2021.1921141] [Reference Citation Analysis]
73 Lee BC, Kang I, Yu KR. Therapeutic Features and Updated Clinical Trials of Mesenchymal Stem Cell (MSC)-Derived Exosomes. J Clin Med 2021;10:711. [PMID: 33670202 DOI: 10.3390/jcm10040711] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
74 Gupta A, Kashte S, Gupta M, Rodriguez HC, Gautam SS, Kadam S. Mesenchymal stem cells and exosome therapy for COVID-19: current status and future perspective. Hum Cell. 2020;33:907-918. [PMID: 32780299 DOI: 10.1007/s13577-020-00407-w] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 15.0] [Reference Citation Analysis]
75 Dutra Silva J, Su Y, Calfee CS, Delucchi KL, Weiss D, McAuley DF, O'Kane C, Krasnodembskaya AD. Mesenchymal stromal cell extracellular vesicles rescue mitochondrial dysfunction and improve barrier integrity in clinically relevant models of ARDS. Eur Respir J 2021;58:2002978. [PMID: 33334945 DOI: 10.1183/13993003.02978-2020] [Cited by in Crossref: 3] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]